Endocrine effects of lithium: II. 'Primary' hyperparathyroidism.
Ninety-six manic-depressive patients were studied during long-term lithium treatment. Highly significant elevations were observed respecting the levels of serum immunoreactive parathyroid hormone (P less than 0.001) as well as the protein-corrected levels of serum calcium (P less than 0.001) and serum magnesium (P less than 0.001), thus indicating a state of 'primary' hyperparathyroidism. The patients as a group had normophosphataemia and normophosphatasia supporting the impression of a rather mild state of biochemical hyperparathyroidism.
D000328:Adult; D000368:Aged; D001714:Bipolar Disorder / Q000188:drug therapy; D001798:Blood Proteins / Q000032:analysis; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000139:chemically induced; D006961:Hyperparathyroidism / Q000139:chemically induced*; D008094:Lithium / Q000009:adverse effects* / Q000627:therapeutic use; D008274:Magnesium / Q000097:blood; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood; D010710:Phosphates / Q000097:blood; D013997:Time Factors
D001798:Blood Proteins; D010281:Parathyroid Hormone; D010710:Phosphates; D008094:Lithium; D008274:Magnesium